EMCDDA Home
  • EN

Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iii) New inpatient clients, ratio of males to females by country and primary drug

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsGender and drug known
Belgium(1)0.0
Bulgaria6.6179
Czech Republic(2)1.90.01.63.04.00.3913
Denmark10.01.01.30.51.872
Germany5.090.07.90.411.311.7514
Estonia0
Ireland2.55.73.70.83.40.0489
Greece8.032.01.22.6774
Spain0
France3.00.012
Italy0
Cyprus(3)1.018
Latvia3.03.31.818.013.31.0431
Lithuania0
Luxembourg0
Hungary1.58.02.032
Malta0
Netherland0
Austria3.07.72.06.0147
Poland0
Portugal0
Romania6.52.05.00.46.06.70.9666
Slovenia0
Slovakia2.41.03.70.57.09.2264
Finland2.31.04.25.05.0122
Sweden(4)1.71.70.91.07.81.8514
United Kingdom2.42.21.62.61.03.32.01076
Croatia3.02.32.00.75.02.2270
Turkey14.94.64.83.227.836.53.01125
Norway0
Total4.14.42.10.96.018.27.21.63.5
Total base366554311674471417313742357618

Notes:

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. 

 (2) For Volatile substances 9 males have been reported 

 (3) For Opioids 8 males have been reported, and for Cocaine 6 males have been reported. 

 (4) For Cocaine 16 males have been reported 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010